LINDSAY HEPLER: Open Payments
NPI 1720054208 · RIMERSBURG, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,031 in 73 payments from 11 companies in 2025. Trend: 2023 $738 · 2024 $768 · 2025 $1,031
Food & beverage: $1,031
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 21 | $270 |
| Lilly USA, LLC | 15 | $260 |
| PFIZER INC. | 16 | $157 |
| ABBVIE INC. | 10 | $157 |
| Exact Sciences Corporation | 3 | $53 |
| Sumitomo Pharma America, Inc. | 2 | $31 |
| Amgen Inc. | 2 | $31 |
| Verona Pharma, Inc. | 1 | $28 |
| GlaxoSmithKline, LLC. | 1 | $15 |
| Abbott Laboratories | 1 | $15 |
Products named: MOUNJARO, Ozempic, NURTEC ODT, QULIPTA, Wegovy, UBRELVY, ELIQUIS, Cologuard Collection Kit.
Industry payments across PA — which companies pay providers there.
